Jessica Hagen
President Biden failed to overturn a U.S. International Trade Commission ban on sales and imports of Watch Series 9 and Watch Ultra 2.
Employers aligned with Carrum can offer two years of treatment coverage to non-metastatic breast cancer patients via Florida Cancer Specialists & Research Institute.
Jay Rughani, investment partner at a16z, discusses 2023 events, predictions for digital health funding in 2024 and proper AI regulation to avoid stifling innovation.
Guidehealth acquired Arcadia's managed services organization and value-based care services division. It also signed an agreement to leverage its data analytics platform.
The award will support veterans' access to the California-based virtual reality company's FDA-authorized at-home chronic low back pain offering, RelieVRx.
The company announced the appointments of numerous individuals to its executive team and will use the funds to expand its partnerships and oncology platform.
The company will use the funds to prepare for commercialization in the U.S., enhance its platform and seek FDA clearance for its VERAFEYE platform.
Leaders in digital health foresee investors having a high bar for funding in 2024, looking toward companies with proven modalities and a clear pathway to profitability.
The two models of MedLM are built on the tech giant's medical LLM Med-PaLM 2, with one designed for complex tasks and the other for scaling across various tasks.
Digital health stakeholders said that AI will be used next year to help ease administrative tasks for providers, improve clinical trial participation and increase transparency in healthcare.